(Q40789349)

23 September 2017

Chronic hepatitis B: new therapies on the horizon? (English)

1 reference

23 September 2017

1 reference

S Pianko

1

1 reference

PubMed ID

10568564

23 September 2017

J McHutchison

series ordinal

2

1 reference

PubMed ID

10568564

23 September 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

23 September 2017

1 reference

23 September 2017

354

1 reference

23 September 2017

9191

1 reference

23 September 2017

1662-1663

1 reference

Global status of hepatitis B immunisation

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900305-0

7 January 2021

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900305-0

7 January 2021

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900305-0

7 January 2021

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900305-0

7 January 2021

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900305-0

7 January 2021

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900305-0

7 January 2021

Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900305-0

7 January 2021

A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900305-0

7 January 2021

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900305-0

7 January 2021

10.1016/S0140-6736(99)00305-0

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

10568564